Tag: am-201

November 20, 2018

Auris Medical Shares Positive FDA Meeting Results

The regulatory agency supports Auris’ plan to conduct multiple doses of AM-201 in a Phase 1 trial with healthy volunteers....
November 20, 2018

Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program

Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental...